Biosensors Market

Biosensors Market for Drug Discovery and Development: Industry Trends and Global Forecasts, till 2035 - Distribution by Type of Biosensor (Optical Biosensors, Electrochemical Biosensors, Thermal Biosensors and Others), Type of End User (Academic and Research Institutes, and Industry Players) and Key Geographies (North America, Europe, Asia Pacific, Middle East and North Africa, Latin America and Rest of the World)

  • Lowest Price Guaranteed From USD 4,799

  • Companies Covered
    113

  • Pages
    217

  • View Count
    15102

Biosensors Market Size & Analysis

The global biosensors market size is estimated to grow from $5.4 billion in 2024 to $14 billion in 2035, growing at a CAGR of 9.0% during the forecast period. The new research study consists of industry trends, detailed market analysis, patent analysis, share analysis, market forecast, and opportunity analysis.

Biosensors Market, by Type of Biosensors, 2024-2035 (USD Billion)

Over the years, the rising risk of chronic and other infectious diseases necessitated the demand for biopharmaceuticals to treat diseases at the cellular level. However, it is well-known that the discovery of viable biologics and drug development is highly complex - it demands high capital investment, skilled personnel, and advanced infrastructure to provide a controlled manufacturing environment. It is worth noting here that around 10-15 years are required to complete the process of drug discovery, development, approval, and commercialization. The entire process of drug discovery requires an average capital investment of 1-2 billion. Owing to certain drug discovery limitations, such as uncontrolled manufacturing environments and lack of standard equipment, only a small proportion of pharmacological leads reach the development stage and are translated into viable final products for further studies.

Despite keen research and standardization, nearly 90% of the drug candidates fail to pass the clinical stage of development. The high abrasion rate has been attributed to the regulatory guidelines for drug approval, which result in more trial and error—ultimately, it leads to failure outcomes and loss of investment. In order to overcome the challenges, including the high requirement of capital investment and prevention of failure outcomes, various industrial leaders are actively exploring the integration of biosensors in drug production. Biosensors are analytical devices consisting of biological components such as antibodies, cells, enzymes, lipids, oligonucleotides, and a physical transducer. These devices enable the screening of pharmacological leads and drug candidates from thousands of hits. These biosensors can also be utilized for day-to-day analysis of known and unknown analytes.

Presently, different biosensors are available, such as electrochemical and optical biosensors; thermal biosensors and others are being utilized across different drug discovery steps, including disease modeling, lead identification, identification / validation, lead optimization, and other applications. Notably, implementing biosensing technologies in various drug discovery operations is expected to enhance the overall research and development process by accurately identifying and screening lead drug compounds. Driven by the benefits of biosensors, the market players are actively developing these innovative technologies to facilitate drug discovery and development. It is worth highlighting here that over 80 biosensors are available in the market / being developed by numerous industrial leaders for drug discovery and development. Considering the ongoing initiatives in this domain, the biosensors market is anticipated to witness substantial growth during the forecast period.

Biosensors Market Segmentation Insights

The market research report presents an in-depth analysis of the various biosensor technologies across different segments, as defined in the table below:

Biosensors Market: Report Attributes / Market Segmentations

Key Report Attribute Details
Historical Trend 2019-2023
Base Year 2023
Forecast Period 2024-2035
Market Size by 2035 USD 14 Billion
Type of Biosensors
  • Optical Biosensors 
  • Electrochemical Biosensors 
  • Others
End Users
  • Academic and Research Institutes 
  • Industry Players
Key Geographical Regions
  • North America 
  • Europe
  • Asia-Pacific 
  • MENA 
  • Latin America 
  • Rest of the World
Key Companies Profiled
  • Agilent Technologies
  • Axion Biosystems
  • BioNavigations
  • Creoptix
  • Cytiva
  • Dynamic Biosensors
  • Malvern Panalytical
  • Microvacuum
  • Sartorius
  • Tempo Bioscience
(A full list of key companies captured is available in the report)
PowerPoint Presentation
(Complimentary)
Available
Customization Scope 15% Free Customization
Excel Data Packs
(Complimentary) 
  • Market Landscape
  • Product Competitiveness Analysis
  • Partnerships and Collaborations
  • Brand Positioning Analysis 
  • Funding and Investment Analysis 
  • Publication Analysis
  • Global Event Analysis
  • Patent Analysis 
  • Market Forecast and Future Opportunity Analysis


One of the key objectives of this market report is to provide a detailed market forecast analysis in order to estimate the existing market size and future opportunities for biosensor companies in the forecast period. We have provided informed estimates of the likely evolution of the biosensors market during the forecast period. Our year-wise projections of the current and future opportunity have further been segmented based on relevant parameters, such as [A] type of biosensor (optical biosensors, electrochemical biosensors, thermal biosensors and others), [B] type of end user (academic and research institutes, and industry players) and [C] key geographies (North America, Europe, Asia Pacific, Middle East and North Africa, Latin America and Rest of the world). In order to account for future uncertainties and to add robustness to our model, we have provided three market forecast scenarios, namely conservative, base, and optimistic scenarios, representing different tracks of the biosensor industry growth.

The opinions and insights presented in the report were also influenced by discussions held with senior stakeholders in the industry. The biosensors market research report features detailed transcripts of interviews held with the following individuals:

  • Chief Executive Officer, Small Company, US
  • Chief Executive Officer, Small Company, US
  • Scientific Director R&D and Head of Biology, Mid-sized Company, France

Biosensors Market Share Insights

Market Share by Type of Biosensors

Based on the type of biosensors, the market is segmented into optical biosensors, electrochemical biosensors, thermal biosensors, and others. According to our projection, optical biosensors will dominate the market and will likely capture 70% of the overall revenue share by 2035. This can be primarily attributed to the growing demand for sensor-based technology to create optimal growing conditions for biologics production.

Market Share by End Users

Based on the type of end user, the market is segmented into academic and research institutes and industry players. Currently, the academic and research institutes are likely to dominate the market and are poised to capture 58% of the overall revenue share by 2035. Industry players will show the highest growth potential in the long run and are expected to grow at a CAGR of 10.1% during the forecast period.

Biosensors Market Key Insights

The "Biosensors Market: Focus on Drug Discovery and Development - Distribution by Type of Biosensor (Optical Biosensors, Electrochemical Biosensors, Thermal Biosensors, and Others), Type of End User (Academic and Research Institutes and Industry Players) and Key Geographies (North America, Europe, Asia Pacific, Latin America, Middle East and North Africa, and Rest of the World) – Industry Trends and Global Forecasts, Till 2035" market report features an extensive study of the current market landscape, market size, and future opportunities associated with biosensor industry, for the given forecast period. The market research report highlights the efforts of several biosensor companies engaged in this emerging and rapidly evolving segment of the pharmaceutical industry.

Biosensors Market: Competitive Landscape

Currently, the global biosensors market features the presence of industry and non-industry players holding the required technical expertise to develop innovative biosensors for accurate disease diagnosis and drug discovery. The biosensor market is dominated by small players, which were established post 2005. Further, the United States has emerged as the key epicenter for drug discovery-focused biosensors, featuring the presence of maximum developers in this industry.

Market Drivers: Increasing Demand for Accurate Diagnostic Tools for Disease Diagnosing and Drug Development

There are several factors driving the growth in the biosensors market. Some of the significant factors include a surge in the requirement for accurate disease diagnostic tools to predict medical conditions and treatment planning. Further, the increasing trend toward point-of-care diagnostic testing has increased the demand for biosensor-based equipment and tools for real-time analysis. In drug discovery, the demand for biosensors to identify leads and maintain optimal conditions for drug development is driving growth in this field.

Market Trends Analysis: Technological Advancements in Biosensors Technologies

Given the rising opportunities to expand existing drug development capabilities with higher accuracy, there has been a surge in the requirement for advanced biosensors in recent years. Further, the growing interest of the population and healthcare experts in smart wearable devices, including biosensors for accurate and real-time health monitoring analysis, is the key trend in this demand. Additionally, the demand for advanced microfabrication technologies for ease of operations and faster drug development is one of the significant trends expected to drive growth in this field. It is interesting to note that over 80 biosensors focused on drug discovery applications are being developed by various industrial players globally; 65% of these biosensors can analyze small molecules. Ongoing biosensor technology innovations such as improvement in sensitivity, specificity, and miniaturization for exploring therapeutic applications in the future are offering enormous opportunities to drive innovations in this field.

Additionally, researchers have also explored several artificial intelligence solutions for driving innovation in drug discovery process. The industry stakeholders are integrating AI with biosensors as well. AI in drug discovery is a lucrative area, with wide scope for development.

Biosensors Market: Funding and Investment Analysis

Driven by the ongoing requirement for advanced biosensors to provide optimal growing conditions, several industry stakeholders raise their funding and investment activities to drive growth in this field. It is worth highlighting here that more than USD 1.2 billion has been invested in this field by both private and public sector stakeholders in the past five years. Notably, nearly 50% of the investment was invested within the past two years, showcasing the increasing interest of the industrial leaders in this domain.

Interestingly, more than 370 patents associated with biosensors in drug discovery have been filed / granted, indicating the continuous pace of innovation in the biosensors market. Owing to the ongoing initiatives on funding and investment by the leading Biosensors Company in this field, the market will witness substantial growth in the upcoming years.

Biosensors Market Size

The global biosensors market size is estimated to reach $14 billion by 2035 driven by the growing demand for advanced analytic technologies to develop target-specific therapies. Further, the quest for innovative technologies to increase research and development activities has underscored the benefits of introducing biosensors in drug discovery, which indicated steady growth in this field during the forecast period. According to the type of biosensors, optical biosensors are likely to show excellent growth potential and are expected to grow at a CAGR of 9.7% during the forecast period.

Regional Analysis: North America Holds the Largest Share of Biosensors Market

Presently, North America will dominate the market and is projected to capture 38% of the market share by 2035. The trend of growth in North America is likely to remain unchanged during the forecast period. This can be attributed to the fact that 60% of the players in this domain are headquartered in North America. Moreover, increasing collaboration and partnership activities between key industrial players in North America are likely to witness steady growth in the forecast period.

Leading Companies in Biosensors Market

Examples of key biosensor companies engaged in supporting drug discovery and development (which have also been profiled in this market report; the complete list of companies is available in the full report) include Agilent Technologies, Axion Biosystems, BioNavigations, Creoptix, Cytiva, Dynamic Biosensors, Malvern Panalytical, Microvacuum, Sartorius and Tempo Bioscience. This biosensors market report includes an easily searchable excel database of all the companies providing biosensors worldwide.

The context of Biosensors Market report, published by Roots Analysis List of Biosensors from the research report of Roots Analysis Current market landscape of Biosensors domain, prepared by Roots Analysis


Biosensors Market Report Coverage

Amongst other elements, the report includes:

  • A detailed assessment of the current market landscape of biosensors in drug discovery, along with information on several relevant parameters, such as type of biosensor (optical biosensors, electrochemical biosensors, quartz crystal microbalance biosensors, thermal biosensors and magneto-electric biosensors), bioreceptor used (cells, proteins, lipids, enzymes, antibodies and undisclosed), drug discovery step(s) supported (disease modeling, target identification / validation, lead identification, lead optimization, and drug discovery (unspecified)), other applications (ADME assays, toxicity assays, cytotoxicity assays, cell analysis, drug characterization / validation assays and other assays), type of analyte analyzed (small molecules, cell / tissues, protein / peptides, antibodies, nucleotides, viruses, blood products, enzymes, biologics (unspecified) and others), type of carrier plate format (microplate-based sensor, flow through the sensor, chip-based static array sensor, polymerase chain reaction (PCR) format plates-based sensor and undisclosed), sample capacity (less than 96, 96 to 384, 385 to 1536, more than 1536 and undisclosed), sample volume (1 to 50µl, 51 to 100 µl, 101 to 200 µl, more than 200 µl and undisclosed), type of detection (label-free and real-time) and type of system (automatic, semi-automatic and undisclosed). In addition, the chapter features analysis related to biosensor developers based on multiple parameters, such as their year of establishment, company size, location of headquarters, and leading players (in terms of number of biosensors developed).
This infographic provides Biosensors market landscape from Roots Analysis report Competitive analysis of Biosensors, from Roots Analysis report This image highlights the brand positioning matrix of Biosensors market
  • A product competitiveness analysis of biosensors used for drug discovery purposes based on various relevant parameters, namely supplier power (in terms of the experience of the developer) and product competitiveness (in terms of the type of biosensor, bioreceptor used, drug discovery step(s) supported, other application(s), type of analyte(s) analyzed, type of carrier plate, sample capacity, type of detection, and type of system used).
  • Elaborate profiles of prominent players developing biosensors for drug discovery applications. Each profile features a brief overview of the company, details related to its product portfolio, recent developments and an informed future outlook.
  • An elaborate brand positioning analysis of leading industry players (shortlisted on the basis of year of establishment, number of biosensors developed, and company size), highlighting the current perceptions regarding their proprietary brands across biosensors in drug discovery.
  • An analysis of investments that have been made into companies developing biosensors for drug discovery applications, including seed financing, venture capital financing, capital raised from IPOs and subsequent offerings, grants, and debt financing. The investment instances have been analyzed based on various relevant parameters, such as year of investment, the amount invested, type of funding, most active players (in terms of the number of funding instances), and type of investor.
  • A detailed review of over 333 peer-reviewed scientific articles related to research on biosensors in drug discovery on the basis of several relevant parameters, such as year of publication, type of publication, emerging focus areas, most active publishers, most active affiliated institutes, and geography. The chapter also highlights the top journals, in terms of number of articles published and impact factor.
  • A detailed analysis of the global events attended by participants, based on several relevant parameters, such as year of event, type of event platform, location of event, emerging focus areas, active organizers (in terms of number of events), active industry and non-industry participants, designation of participants, and affiliated organizations of participant. The chapter also highlights the geographical mapping of upcoming events.
  • An in-depth analysis of various patents that have been filed / granted related to biosensors in drug discovery during the period 2018-2024, taking into consideration parameters such as publication year, geographical region, CPC symbols, patent focus areas, type of applicant, detailed valuation analysis and leading players (in terms of size of intellectual property portfolio).
This image provides information on investments received by the companies engaged in Biosensors Market This image provides information on patents that have been filed / granted related to Biosensors The current and future market trends of Biosensors Market according to Roots Analysis


Recent Developments in Biosensors Market

Several recent developments have taken place in the field of biosensors. We have outlined some of these recent initiatives below. These developments, even if they took place post the release of our market report, substantiate the overall market trends that have been outlined in our biosensors market analysis.

  • In June 2023, GrapheneDx entered into a strategic partnership with Sapphiros to industrialize graphene-based biosensors which will be utilized to diagnose various diseases at the point-of-care and in consumer settings.
  • In April 2023, IIT Bhubaneshwar entered into collaboration with AIIMS Bhubaneshwar to integrate artificial intelligence with medical science. Additionally, the partnership focuses on biomedical signal processing, advanced characterization, and biosensor development for mental health.
  • In March 2023, Pusan National University announced that they had developed a novel biosensor to detect DNA damage in real time.
  • In September 2022, 2bind and Dynamic Biosensors signed a technology service partnership, under which the former will provide access to Dynamic Biosensors’ innovative heliX® system to its clients seeking service for early stage drug discovery.

Frequently Asked Questions

Question 1: What are biosensors?

Answer: Biosensors refer to a class of analytical devices which incorporate microorganisms or biomolecules for the detection of chemicals.

Question 2: How big is the biosensor market?

Answer: The biosensor market size is estimated to be worth $14 billion by 2035.

Question 3: What is the projected market growth of the biosensors market for drug discovery and development?

Answer: The biosensors market is expected to grow at a compounded annual growth rate (CAGR) of 9% during the forecast period.

Question 4: Who are the leading companies in the biosensors market for drug discovery and development?

Answer: Agilent Technologies, Axion Biosystems, BioNavigations, Creoptix, Cytiva, Dynamic Biosensors, Malvern Panalytical, Microvacuum, Sartorius and Tempo Bioscience.

Question 5: How many patents have been filed / granted to date related to biosensors for drug discovery and development?

Answer: Till date, over 370 patents have been filed / granted related to the biosensors for drug discovery and development.

Question 6: Which type of biosensor is primarily developed by the biosensor companies supporting drug discovery and development?

Answer: Close to 65% of the companies are developing optical biosensors.

Question 7: Which region is the hub for companies engaged in the biosensors market for drug discovery and development?

Answer: North America emerged as the hub with over 60% of the players established in the region.

Question 8: What is the application of biosensors in drug discovery and development?

Answer: Biosensors are being deployed across different steps of drug discovery, such as disease modeling, target identification / validation, lead identification, lead optimization, and other applications.

PRICING DETAILS

This license grants the right of use of the purchased report to a single recipient only (normally the person who buys the report). You may access the material on your computer, as and when required, for your own personal use. You may also print Read more about Single-User License

This license grants the right of use of the purchased report by the employees of a business unit at a particular site/office location. The report may be accessed on the computer of any employee within the business unit. You may also print multiple Read more about One Location Site License

This license grants the right of use of the purchased report by a department / team of individuals (up to 12) in a particular organization. The license does not limit the use to a particular site / office location. The report may be accessed on the computer Read more about Department License

This license entitles the buyer of the report to share, distribute the report (either full or in part) with other employees of the same firm/enterprise. The report may be accessed by any employee of the enterprise and there is no limit on the Read more about Enterprise License

Discounts available for multiple report purchases
Click here to send an email to Roots Analysis team. sales@rootsanalysis.com